Skip to content

13G filed by Redmile Group, LLC

Redmile Group, LLC and 2 other reporting persons reported 5,462,881 shares of Electra Therapeutics, Inc., 8.7% of the class, as of 2026-09-21, in a 13G accepted by EDGAR 2026-09-29 01:00:40 UTC.

Accession
0001104659-26-111478
Filed
2026-09-28
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Subject
Electra Therapeutics, Inc.
Shares
5,462,881
Percent of class
8.7%
Event date
2026-09-21

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group Redmile Group, LLC.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Redmile Group, LLCIA,OO05,462,88105,462,8815,462,8818.7%
Jeremy C. GreenHC,IN05,462,88105,462,8815,462,8818.7%
Redmile Biopharma Investments II, L.P.PN04,796,21504,796,2154,796,2157.6%